Mounjaro vs Wegovy: What’s the Difference?
How They Work
Mounjaro (Tirzepatide) – Dual-acting medication that targets both GIP and GLP-1 receptors, helping regulate appetite and blood sugar.
Wegovy (Semaglutide) – Focuses on GLP-1 receptors alone, promoting satiety and slower digestion.
Mounjaro’s dual action often leads to more significant weight loss, but both drugs are highly effective and clinically proven.
Weight Loss Results
Studies suggest Mounjaro users may achieve slightly higher weight reduction on average compared to Wegovy. However, results vary between individuals, and success depends on factors like diet, exercise, and consistency.
Dosing and Side Effects
Both are once-weekly injections with gradual dose increases.
Common side effects include nausea, bloating, and reduced appetite, these often ease over time.
Wegovy’s slower titration can make it easier for some users to tolerate, while Mounjaro’s flexibility can be beneficial for those already experienced with GLP-1 therapy.
Cost and Access
Due to recent price adjustments, Mounjaro may be more expensive than Wegovy in the private market.
Availability can also vary between pharmacies and providers, making it worth reviewing both options before starting treatment.
Which Is Right for You?
There’s no single “better” choice, it depends on your health goals, tolerance, and budget.
A medical professional can help you decide which medication best fits your lifestyle and needs.
Both Mounjaro and Wegovy are effective, modern treatments for weight management. The best choice depends on your personal goals and how your body responds.
At Treat Discreet, our clinicians can help you decide which option is most suitable for you.
